SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001558370-24-005201
Filing Date
2024-04-16
Accepted
2024-04-16 16:56:52
Documents
13
Period of Report
2022-04-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A mgtx-20220425x8ka.htm   iXBRL 8-K/A 32433
  Complete submission text file 0001558370-24-005201.txt   151092

Data Files

Seq Description Document Type Size
2 EX-101.SCH mgtx-20220425.xsd EX-101.SCH 3120
3 EX-101.LAB mgtx-20220425_lab.xml EX-101.LAB 15927
4 EX-101.PRE mgtx-20220425_pre.xml EX-101.PRE 10052
16 EXTRACTED XBRL INSTANCE DOCUMENT mgtx-20220425x8ka_htm.xml XML 4865
Mailing Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016
Business Address 450 EAST 29TH STREET 15TH FLOOR NEW YORK NY 10016 6464902965
MeiraGTx Holdings plc (Filer) CIK: 0001735438 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38520 | Film No.: 24848516
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)